vs
美森（MATX）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
美森的季度营收约是Pediatrix Medical Group, Inc.的1.7倍（$851.9M vs $493.8M），美森净利率更高（16.8% vs 6.8%，领先10.0%），Pediatrix Medical Group, Inc.同比增速更快（-1.7% vs -4.3%），过去两年美森的营收复合增速更高（8.6% vs -0.1%）
美森公司（Matson, Inc.）是美国知名航运服务企业，总部位于夏威夷州火奴鲁鲁，成立于1882年。旗下子公司美森航运主营跨太平洋海运业务，服务覆盖夏威夷、阿拉斯加、关岛、密克罗尼西亚、太平洋诸岛、中国及日本等地区。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
MATX vs MD — 直观对比
营收规模更大
MATX
是对方的1.7倍
$493.8M
营收增速更快
MD
高出2.6%
-4.3%
净利率更高
MATX
高出10.0%
6.8%
两年增速更快
MATX
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $851.9M | $493.8M |
| 净利润 | $143.1M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 16.9% | 9.9% |
| 净利率 | 16.8% | 6.8% |
| 营收同比 | -4.3% | -1.7% |
| 净利润同比 | 11.8% | 10.5% |
| 每股收益（稀释后） | $4.47 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATXMD
| Q4 25 | $851.9M | $493.8M | ||
| Q3 25 | $880.1M | $492.9M | ||
| Q2 25 | $830.5M | $468.8M | ||
| Q1 25 | $782.0M | $458.4M | ||
| Q4 24 | $890.3M | $502.4M | ||
| Q3 24 | $962.0M | $511.2M | ||
| Q2 24 | $847.4M | $504.3M | ||
| Q1 24 | $722.1M | $495.1M |
净利润MATXMD
| Q4 25 | $143.1M | $33.7M | ||
| Q3 25 | $134.7M | $71.7M | ||
| Q2 25 | $94.7M | $39.3M | ||
| Q1 25 | $72.3M | $20.7M | ||
| Q4 24 | $128.0M | $30.5M | ||
| Q3 24 | $199.1M | $19.4M | ||
| Q2 24 | $113.2M | $-153.0M | ||
| Q1 24 | $36.1M | $4.0M |
营业利润率MATXMD
| Q4 25 | 16.9% | 9.9% | ||
| Q3 25 | 18.3% | 13.8% | ||
| Q2 25 | 13.6% | 12.8% | ||
| Q1 25 | 10.5% | 7.0% | ||
| Q4 24 | 16.6% | 7.8% | ||
| Q3 24 | 25.2% | 6.6% | ||
| Q2 24 | 14.7% | -31.3% | ||
| Q1 24 | 5.1% | 3.2% |
净利率MATXMD
| Q4 25 | 16.8% | 6.8% | ||
| Q3 25 | 15.3% | 14.5% | ||
| Q2 25 | 11.4% | 8.4% | ||
| Q1 25 | 9.2% | 4.5% | ||
| Q4 24 | 14.4% | 6.1% | ||
| Q3 24 | 20.7% | 3.8% | ||
| Q2 24 | 13.4% | -30.3% | ||
| Q1 24 | 5.0% | 0.8% |
每股收益（稀释后）MATXMD
| Q4 25 | $4.47 | $0.40 | ||
| Q3 25 | $4.24 | $0.84 | ||
| Q2 25 | $2.92 | $0.46 | ||
| Q1 25 | $2.18 | $0.24 | ||
| Q4 24 | $3.69 | $0.37 | ||
| Q3 24 | $5.89 | $0.23 | ||
| Q2 24 | $3.31 | $-1.84 | ||
| Q1 24 | $1.04 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.9M | $375.2M |
| 总债务越低越好 | $361.2M | $570.5M |
| 股东权益账面价值 | $2.8B | $865.9M |
| 总资产 | $4.6B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.13× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资MATXMD
| Q4 25 | $141.9M | $375.2M | ||
| Q3 25 | $92.7M | $340.1M | ||
| Q2 25 | $59.1M | $224.7M | ||
| Q1 25 | $122.0M | $99.0M | ||
| Q4 24 | $266.8M | $229.9M | ||
| Q3 24 | $270.3M | $103.8M | ||
| Q2 24 | $168.2M | $19.4M | ||
| Q1 24 | $25.9M | $8.0M |
总债务MATXMD
| Q4 25 | $361.2M | $570.5M | ||
| Q3 25 | $370.9M | $577.2M | ||
| Q2 25 | $341.3M | $583.9M | ||
| Q1 25 | $351.1M | $590.5M | ||
| Q4 24 | $361.2M | $597.1M | ||
| Q3 24 | $370.9M | — | ||
| Q2 24 | $381.0M | — | ||
| Q1 24 | $390.8M | — |
股东权益MATXMD
| Q4 25 | $2.8B | $865.9M | ||
| Q3 25 | $2.7B | $890.7M | ||
| Q2 25 | $2.6B | $833.8M | ||
| Q1 25 | $2.6B | $789.2M | ||
| Q4 24 | $2.7B | $764.9M | ||
| Q3 24 | $2.6B | $732.5M | ||
| Q2 24 | $2.4B | $706.5M | ||
| Q1 24 | $2.4B | $856.2M |
总资产MATXMD
| Q4 25 | $4.6B | $2.2B | ||
| Q3 25 | $4.6B | $2.2B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.5B | $2.0B | ||
| Q4 24 | $4.6B | $2.2B | ||
| Q3 24 | $4.4B | $2.1B | ||
| Q2 24 | $4.3B | $2.0B | ||
| Q1 24 | $4.2B | $2.2B |
负债/权益比MATXMD
| Q4 25 | 0.13× | 0.66× | ||
| Q3 25 | 0.14× | 0.65× | ||
| Q2 25 | 0.13× | 0.70× | ||
| Q1 25 | 0.13× | 0.75× | ||
| Q4 24 | 0.14× | 0.78× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.16× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $176.9M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $42.2M | — |
| 自由现金流率自由现金流/营收 | 5.0% | — |
| 资本支出强度资本支出/营收 | 15.8% | — |
| 现金转化率经营现金流/净利润 | 1.24× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $153.7M | — |
8季度趋势，按日历期对齐
经营现金流MATXMD
| Q4 25 | $176.9M | $114.1M | ||
| Q3 25 | $175.6M | $137.3M | ||
| Q2 25 | $105.6M | $137.2M | ||
| Q1 25 | $89.0M | $-117.5M | ||
| Q4 24 | $174.7M | $133.0M | ||
| Q3 24 | $248.6M | $91.8M | ||
| Q2 24 | $307.9M | $107.0M | ||
| Q1 24 | $36.6M | $-125.2M |
自由现金流MATXMD
| Q4 25 | $42.2M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $19.3M | — | ||
| Q1 25 | $-200.0K | — | ||
| Q4 24 | $49.3M | — | ||
| Q3 24 | $189.0M | — | ||
| Q2 24 | $238.1M | — | ||
| Q1 24 | $-18.7M | — |
自由现金流率MATXMD
| Q4 25 | 5.0% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | -0.0% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 28.1% | — | ||
| Q1 24 | -2.6% | — |
资本支出强度MATXMD
| Q4 25 | 15.8% | — | ||
| Q3 25 | 9.5% | — | ||
| Q2 25 | 10.4% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 8.2% | — | ||
| Q1 24 | 7.7% | — |
现金转化率MATXMD
| Q4 25 | 1.24× | 3.39× | ||
| Q3 25 | 1.30× | 1.91× | ||
| Q2 25 | 1.12× | 3.49× | ||
| Q1 25 | 1.23× | -5.66× | ||
| Q4 24 | 1.36× | 4.36× | ||
| Q3 24 | 1.25× | 4.72× | ||
| Q2 24 | 2.72× | — | ||
| Q1 24 | 1.01× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MATX
| Ocean Transportation Segment | $704.2M | 83% |
| Logistics Services Segment | $147.7M | 17% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
